Bigbloc Construction

-
Dear Blog Readers,

Bigbloc Construction at current market price of 78 looks bullish technically and Fundamentally.

Bigbloc Construction
Cmp 78
Market Cap 110.50 Cr
Face Value 10
Dividend Yield 51%

Reason of This stock to select :-
1) company is going to expand its AAC Block business plant by setting up new AAC (Areated Autoclave concrete)  plant at Umargam,  Dist Valsad,  Gujarat

2) Setting up new AAC (Areated Autoclave concrete)  plant at Bangalore.

3) Board meeting on 11 April 2017.

4)  Company is Regular Paying Dividend.

5) Promoter stake increased in last Quarter upto 70.34%.. Promoters also buying from last two days from the  market. . . .

6) Technically Breakout seen.


Company website :- http://www.nxtbloc.in

Stock can reach at 85,90,100 within short period of time.  One can buy this  stock for Long term investment also.  

==========================
Disclaimer:- 
This is a personal blog and presents entirely personal views on stock market. Any statement made in this blog is merely an expression of my personal opinion. These informations are sourced from publicly available data. By using/reading this blog you agree to (i) not to take any investment decision or any other important decisions based on any information, opinion, suggestion, expressions or experience mentioned or presented in this blog (ii) Any investment decisions taken if any would be his/hers sole responsibility. (iii) the author of this blog is not responsible. 




Comments

  1. STOCK TIGERSApril 11, 2017 at 4:12 AM

    *Board of BIGBLOC Construction approves Rs 100 crore capex for expansion of AAC Blocks*

    Capital Market |  Apr 11, 2017 02:35 PM IST


    At meeting held on 11 April 2017

    BIGBLOC Construction announced that the Board of Directors of the Company at its meeting held on 11 April 2017 approved the following expansion for AAC Blocks :

    1. Brownfield Expansion of 3,00,000 cubic meters per annum at the Company's plant situated at Umargaon (Gujarat).

    ```This will make the Umargaon Plant the largest capacity plant at a single location in India at 6,00,000 cubic meters per annum```

    2. *Greenfield expansion of 3,00,000 cubic meters per annum at Bangalore.*

    As a result of the above expansions, the Company's total AAC Blocks capacity will become 9,00,000 cubic meters per annum. The total Capital Expenditure envisaged is approx. Rs.100 crore. The Capital Expenditure will be financed through a mix of Debt & Equity.

    ReplyDelete
  2. AnonymousApril 13, 2017 at 12:27 AM

    Hi. What will be the target for this scrip, short term and long term?

    ReplyDelete
  3. AnonymousApril 18, 2017 at 7:17 PM

    According to moneycontrol app, dividend history not impressive. Please update.

    ReplyDelete
  4. STOCK TIGERSJune 4, 2017 at 10:05 AM

    I have big Target, Today's closing price is 92...

    I am seeing 135 till the end of December 2017

    ReplyDelete
  5. VijayaAugust 26, 2017 at 2:09 AM

    Hey very nice blog!!
    Hi there,I enjoy reading through your article post, I wanted to write a little comment to support you and wish you a good continuationAll the best for all your blogging efforts.Aditya Constructions Reviews

    ReplyDelete
  6. CSDecember 2, 2017 at 7:59 AM

    Is 135 the final target

    ReplyDelete
  7. STOCK TIGERSDecember 10, 2017 at 10:12 AM

    New 52 week high 129.95

    ReplyDelete
  8. UnknownMarch 21, 2018 at 5:22 AM

    Is it worth buying now

    ReplyDelete

Post a Comment

Popular posts from this blog

IOL Chemicals And Pharmaceuticals Limited

-
Image
IOL Chemicals And Pharmaceuticals Limited (CMP 82.30) COMPANY OVERVIEW :- Company was established in 1986, IOLCP is India's one of the leading generic pharmaceutical company, and is significant player in the Organic chemicals space. IOLCP has wide presence across various therapeutic categories like, Pain Management, Anti-diabetic, Anti-hypertensive, Anti Convulsants, etc.  IOLCP  is the second largest producer of  Ibuprofen  in India and fifth largest in the  world . Company is engaged in pharma and speciality chemical business,  It is one of the largest producer of ethyle Acetate (87,000 TPA) and ISO Butyl Benzene (IBB) in India with over 30% of the global market share and a major player in Ibuprofen. It has forward-integrated this vertical to the pharmaceutical segment with end products such as  ethyle Acetate, Acytile chloride use in as key raw material for ibr...
Read more

ALUFLUORIDE Ltd. (Once again)

-
Image
Dear blog Readers,                           ALUFLUORIDE  was recommended on 12/05/2017 at 64.                          ALUFLUORIDE  made new 52 week high of 199 on 06/09/18 and achieved my all Target. click here :-  https://hiteshyadav.blogspot.com/2018/10/alufluoride-200-multibagger-returns.html OLD UPDATES OF  ALUFLUORIDE   ON BLOG :-  Link to ALUFLUORIDE old call :-  Click here once again  ALUFLUORIDE is looking good at 120 levels. =========================================================== Name of Stock :- Alufluoride Ltd. (cmp 123) COMPANY PROFILE :-  Alufluoride Limited started the project in 1993 for producing Aluminium Fluoride and related products. The project was completed in record time at a cost of Rs.200 million. Trial runs commenced in Nov, 1994 and a quality ...
Read more

NGL Finechem Ltd.

-
Image
NGL Finechem Ltd.  c mp :- 455 CODE - 524774 COMPANY OVERVIEW :- NGL Fine-Chem Ltd is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. Manufacture APIs and Finished Formulations for usage in Human & Veterinary health. Have over 30 years experience in manufacturing and we cater to various multinational companies to manufacture high quality products with reliability and flexibility. Core expertise in multi stage organic synthesis of APIs and Fine Chemicals helps us support customers with unique and challenging manufacturing requirements. Export to over 35 countries globally and all our products are supported with Drug Master Files. Operates in 3 cGMP facilities around mumbai.    These plants have been designed to meet the requirements of Drug regulatory agencies and are capable of a wide range of reaction capabilities. Company is more focused into veterinary APIs. Though they do veterinary formula...
Read more